Spirometry in the Lung Health Study: 1. Methods and quality control

P. L. Enright, L. R. Johnson, J. E. Connett, H. Voelker, A (Sonia) Buist

Research output: Contribution to journalArticle

231 Citations (Scopus)

Abstract

The Lung Health Study is a randomized clinical trial designed to determine whether a smoking intervention program and prescription of an inhaled bronchodilator can reduce the annual rate of decline of FEV1 (FEV1 slope) in cigarette smokers with mild to moderate airflow limitation. During the recruitment period, spirometry measurements were obtained during three screening visits from 5,887 cigarette smokers 35 to 60 yr of age. To improve the statistical power of the study to detect significant differences in the FEV1 slopes among study groups, the spirometry testing protocol carefully controls for multiple factors that are known to increase intraindividual variability of FEV1 and FVC results. These factors include participant preparation, maneuver acceptability and reproducibility, technician training and performance monitoring, equipment design and calibration, and result processing. The objective of this report is to describe the success of the spirometry quality control program in minimizing the short-term intraindividual FEV1 variability. The mean difference between the FEV1 values obtained at the second and third screening visits (mean 25 days apart) was +5.7 ml in women and -14.7 ml in men, with a mean intraindividual variability of 119 ml in women and 162 ml in men, with a coefficient of variation of 5.8% for both. During only 2.1% of the test sessions were participants unable to produce three acceptable FVC maneuvers with the two best FEV1 values matching within 5% or 100 ml. Institution of site visits and technician performance monitoring was associated with improved test session quality grades and maintenance of high quality grades thereafter.

Original languageEnglish (US)
Pages (from-to)1215-1223
Number of pages9
JournalAmerican Review of Respiratory Disease
Volume143
Issue number6
StatePublished - 1991
Externally publishedYes

Fingerprint

Spirometry
Quality Control
Tobacco Products
Lung
Health
Equipment Design
Bronchodilator Agents
Calibration
Prescriptions
Randomized Controlled Trials
Smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Enright, P. L., Johnson, L. R., Connett, J. E., Voelker, H., & Buist, A. S. (1991). Spirometry in the Lung Health Study: 1. Methods and quality control. American Review of Respiratory Disease, 143(6), 1215-1223.

Spirometry in the Lung Health Study : 1. Methods and quality control. / Enright, P. L.; Johnson, L. R.; Connett, J. E.; Voelker, H.; Buist, A (Sonia).

In: American Review of Respiratory Disease, Vol. 143, No. 6, 1991, p. 1215-1223.

Research output: Contribution to journalArticle

Enright, PL, Johnson, LR, Connett, JE, Voelker, H & Buist, AS 1991, 'Spirometry in the Lung Health Study: 1. Methods and quality control', American Review of Respiratory Disease, vol. 143, no. 6, pp. 1215-1223.
Enright, P. L. ; Johnson, L. R. ; Connett, J. E. ; Voelker, H. ; Buist, A (Sonia). / Spirometry in the Lung Health Study : 1. Methods and quality control. In: American Review of Respiratory Disease. 1991 ; Vol. 143, No. 6. pp. 1215-1223.
@article{f7d0c819665e45678bc758895de825c5,
title = "Spirometry in the Lung Health Study: 1. Methods and quality control",
abstract = "The Lung Health Study is a randomized clinical trial designed to determine whether a smoking intervention program and prescription of an inhaled bronchodilator can reduce the annual rate of decline of FEV1 (FEV1 slope) in cigarette smokers with mild to moderate airflow limitation. During the recruitment period, spirometry measurements were obtained during three screening visits from 5,887 cigarette smokers 35 to 60 yr of age. To improve the statistical power of the study to detect significant differences in the FEV1 slopes among study groups, the spirometry testing protocol carefully controls for multiple factors that are known to increase intraindividual variability of FEV1 and FVC results. These factors include participant preparation, maneuver acceptability and reproducibility, technician training and performance monitoring, equipment design and calibration, and result processing. The objective of this report is to describe the success of the spirometry quality control program in minimizing the short-term intraindividual FEV1 variability. The mean difference between the FEV1 values obtained at the second and third screening visits (mean 25 days apart) was +5.7 ml in women and -14.7 ml in men, with a mean intraindividual variability of 119 ml in women and 162 ml in men, with a coefficient of variation of 5.8{\%} for both. During only 2.1{\%} of the test sessions were participants unable to produce three acceptable FVC maneuvers with the two best FEV1 values matching within 5{\%} or 100 ml. Institution of site visits and technician performance monitoring was associated with improved test session quality grades and maintenance of high quality grades thereafter.",
author = "Enright, {P. L.} and Johnson, {L. R.} and Connett, {J. E.} and H. Voelker and Buist, {A (Sonia)}",
year = "1991",
language = "English (US)",
volume = "143",
pages = "1215--1223",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Spirometry in the Lung Health Study

T2 - 1. Methods and quality control

AU - Enright, P. L.

AU - Johnson, L. R.

AU - Connett, J. E.

AU - Voelker, H.

AU - Buist, A (Sonia)

PY - 1991

Y1 - 1991

N2 - The Lung Health Study is a randomized clinical trial designed to determine whether a smoking intervention program and prescription of an inhaled bronchodilator can reduce the annual rate of decline of FEV1 (FEV1 slope) in cigarette smokers with mild to moderate airflow limitation. During the recruitment period, spirometry measurements were obtained during three screening visits from 5,887 cigarette smokers 35 to 60 yr of age. To improve the statistical power of the study to detect significant differences in the FEV1 slopes among study groups, the spirometry testing protocol carefully controls for multiple factors that are known to increase intraindividual variability of FEV1 and FVC results. These factors include participant preparation, maneuver acceptability and reproducibility, technician training and performance monitoring, equipment design and calibration, and result processing. The objective of this report is to describe the success of the spirometry quality control program in minimizing the short-term intraindividual FEV1 variability. The mean difference between the FEV1 values obtained at the second and third screening visits (mean 25 days apart) was +5.7 ml in women and -14.7 ml in men, with a mean intraindividual variability of 119 ml in women and 162 ml in men, with a coefficient of variation of 5.8% for both. During only 2.1% of the test sessions were participants unable to produce three acceptable FVC maneuvers with the two best FEV1 values matching within 5% or 100 ml. Institution of site visits and technician performance monitoring was associated with improved test session quality grades and maintenance of high quality grades thereafter.

AB - The Lung Health Study is a randomized clinical trial designed to determine whether a smoking intervention program and prescription of an inhaled bronchodilator can reduce the annual rate of decline of FEV1 (FEV1 slope) in cigarette smokers with mild to moderate airflow limitation. During the recruitment period, spirometry measurements were obtained during three screening visits from 5,887 cigarette smokers 35 to 60 yr of age. To improve the statistical power of the study to detect significant differences in the FEV1 slopes among study groups, the spirometry testing protocol carefully controls for multiple factors that are known to increase intraindividual variability of FEV1 and FVC results. These factors include participant preparation, maneuver acceptability and reproducibility, technician training and performance monitoring, equipment design and calibration, and result processing. The objective of this report is to describe the success of the spirometry quality control program in minimizing the short-term intraindividual FEV1 variability. The mean difference between the FEV1 values obtained at the second and third screening visits (mean 25 days apart) was +5.7 ml in women and -14.7 ml in men, with a mean intraindividual variability of 119 ml in women and 162 ml in men, with a coefficient of variation of 5.8% for both. During only 2.1% of the test sessions were participants unable to produce three acceptable FVC maneuvers with the two best FEV1 values matching within 5% or 100 ml. Institution of site visits and technician performance monitoring was associated with improved test session quality grades and maintenance of high quality grades thereafter.

UR - http://www.scopus.com/inward/record.url?scp=0025810969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025810969&partnerID=8YFLogxK

M3 - Article

C2 - 2048803

AN - SCOPUS:0025810969

VL - 143

SP - 1215

EP - 1223

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -